NEW YORK, NY / ACCESSWIRE / January 29, 2018 / All three major indexes closed the week at record highs Friday as corporate earnings continue to impress investors. The Dow Jones Industrial Average gained 0.85 percent to close at 26,616.71, while the S&P 500 Index jumped 1.18 percent to close at 2,872.87. The Nasdaq Composite Index spiked 1.28 percent to close at 7,505.77. The Dow, Nasdaq and S&P 500 all posted weekly gains of more than 2 percent.
"The beat rates and growth rates are as good as we have measured for these 133 companies in any earnings season over the past five years," said Nick Raich, CEO of The Earnings Scout, in a note, according to CNBC. "Most importantly, 1Q 2018 EPS estimates are rising and that is the first time we have seen aggregate S&P 500 EPS estimates going higher in any earnings season in seven years."
RDI Initiates Coverage on:
Atossa Genetics Inc.
Atossa Genetics stock jumped 29.19% Friday, to close the day at $0.42. The stock recorded a trading volume of 17,610,125 shares, which was above its three months average volume of 1,993,239 shares. In the last year, Atossa Genetics shares have traded in a range of 0.22 - 1.85. The share price has gained 90.91% from its 52 week low. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $0.29 is below its 200-day moving average of $0.41. Shares of Atossa Genetics have gained roughly 79.1 percent in the past month and are up 59.7 percent year-to-date.
Access RDI’s Atossa Genetics Inc. Research Report at:
On Friday, shares of Pulmatrix recorded a trading volume of 5,293,969 shares, which was above the three months average volume of 335,454 shares. The stock ended the day 18.45% higher at 1.99. The share price has gained 47.41% from its 52 week low with a 52 week trading range of 1.35 - 6.98.The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $1.52 is below its 200-day moving average of $1.80. Shares of Pulmatrix have gained roughly 37.24 percent in the past month and are up 41.13 percent year-to-date.
Access RDI’s Pulmatrix, Inc. Research Report at:
Research Driven Investing
We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.
RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.
Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.
For any questions, inquiries, or comments reach out to us directly at:
Research Driven Investing, Unit #901 511 Avenue of the Americas, New York, NY, 10011
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.